Condition: Diabetic Foot Ulcer · Sponsor: Organogenesis
This prospective, multi-center, randomized, controlled modified platform Trial compares Purified Native Type 1 Collagen Extracellular Matrix with Polyhexamethylene Biguanide Antimicrobial (PCMP) and Standard of Care versus Standard of Care Alone in subjects with chronic DFUs.
This description comes directly from the study's public registry record.
Brett Madden · (781) 575-0775 · bmadden@organo.com
Meghan Byrd · (781) 575-0775 · mbyrd@organo.com
Always discuss trial participation with your own doctor first.
| Kent State University, College of Podiatric Medicine | Clevland, Ohio, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06618612